Last reviewed · How we verify
Geninax (GARENOXACIN)
At a glance
| Generic name | GARENOXACIN |
|---|---|
| Drug class | garenoxacin |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
| First approval | 2007 |
Approved indications
- Bacterial pneumonia
- Infective laryngitis
- Infective otitis media
- Peritonsillar abscess
- Sinusitis
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Geninax CI brief — competitive landscape report
- Geninax updates RSS · CI watch RSS